Coronary Atherosclerosis Evaluation by Arterial Wall MRI

动脉壁 MRI 评估冠状动脉粥样硬化

基本信息

  • 批准号:
    7256403
  • 负责人:
  • 金额:
    $ 62.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-08-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Direct and noninvasive visualization of the extent of coronary artery atherosclerosis is a major goal in the effort to assess coronary heart disease. Coronary artery calcium and carotid intima medial thickness are examples of surrogate markers of coronary atherosclerosis that attempt to non-invasively define the extent of coronary artery disease present. Coronary calcium in particular is a marker for coronary atherosclerotic burden but is a minor component of total plaque and is not present in early plaque. Coronary artery wall MRI is a new method to directly measure the thickness of the coronary artery wall, and is the only existing noninvasive test without ionizing radiation that can directly interrogate the coronary vasculature and provide a measure of disease burden at this early stage. Prior studies have shown increased coronary artery wall thickness is detected by MRI when no or minimal narrowing of the coronary artery lumen is present. Thus, this study proposes to assess the role of coronary artery wall thickness as a measure of early atherosclerotic disease using MRI, and 2) to determine the relationship of coronary artery wall thickness to both known risk and other noninvasive surrogate markers of atherosclerosis. This study will be performed within the context of the Multi-Ethnic Study of Atherosclerosis (MESA), an NHBLI prospective study of 6814 subjects without clinically manifest atherosclerotic disease. The underlying hypothesis of the MESA study is that the pathway from risk factors to clinical disease is through the development of subclinical disease. The MESA cohort is well characterized in terms of traditional risk factors and serologic markers for atherosclerotic disease. There is also phenotypic characterization of the cohort using carotid ultrasound, coronary calcium and MRI of the carotid and aortic wall. The specific aims of this application are to 1) determine the relationship between known risk factors for cardiovascular disease and coronary artery wall thickness, 2) determine the relationship between coronary artery wall thickness and coronary artery calcium and carotid wall thickness and 3) measure the progression of coronary artery wall thickness over time. The combination of direct coronary artery wall thickness measurement by MRI with the existing disease markers in MESA will be an effective way to assess the relationship of these markers to early pathologic changes in the coronary arterial bed. The ability to directly define the extent of coronary atherosclerosis at an early stage should lead to an improved understanding of coronary risk factors and their impact on atherosclerosis development.
描述(由申请人提供):冠状动脉粥样硬化程度的直接和无创可视化是评估冠心病的主要目标。冠状动脉钙化和颈动脉内膜中层厚度是冠状动脉粥样硬化的替代标志物的实例,其试图非侵入性地定义冠状动脉疾病存在的程度。特别是冠状动脉钙是冠状动脉粥样硬化负荷的标志物,但它是总斑块的次要成分,不存在于早期斑块中。冠状动脉壁MRI是一种直接测量冠状动脉壁厚度的新方法,并且是唯一现有的无电离辐射的无创测试,可以直接询问冠状动脉血管并在此早期阶段提供疾病负担的测量。先前的研究表明,当冠状动脉腔没有狭窄或狭窄程度很小时,MRI可检测到冠状动脉壁厚度增加。因此,本研究建议使用MRI评估冠状动脉壁厚度作为早期动脉粥样硬化疾病的测量值的作用,以及2)确定冠状动脉壁厚度与动脉粥样硬化的已知风险和其他非侵入性替代标志物的关系。本研究将在多种族动脉粥样硬化研究(梅萨)的背景下进行,MESA是一项NHBLI前瞻性研究,纳入了6814例无临床表现动脉粥样硬化疾病的受试者。梅萨研究的基本假设是,从危险因素到临床疾病的途径是通过亚临床疾病的发展。梅萨队列在动脉粥样硬化疾病的传统危险因素和血清学标志物方面得到了很好的表征。还使用颈动脉超声、冠状动脉钙和颈动脉和主动脉壁的MRI对队列进行表型表征。本申请的具体目的是:1)确定心血管疾病的已知风险因素与冠状动脉壁厚度之间的关系,2)确定冠状动脉壁厚度与冠状动脉钙和颈动脉壁厚度之间的关系,以及3)测量冠状动脉壁厚度随时间的进展。MRI直接测量冠状动脉壁厚度与梅萨中现有的疾病标志物相结合,将是评估这些标志物与冠状动脉床早期病理变化关系的有效方法。在早期阶段直接确定冠状动脉粥样硬化程度的能力将导致对冠状动脉危险因素及其对动脉粥样硬化发展的影响的更好理解。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN S LEWIN其他文献

JONATHAN S LEWIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN S LEWIN', 18)}}的其他基金

Developing an NHP model for understanding the biological causes of long COVID-19 pathogenesis
开发 NHP 模型以了解 COVID-19 长期发病机制的生物学原因
  • 批准号:
    10404760
  • 财政年份:
    2021
  • 资助金额:
    $ 62.09万
  • 项目类别:
Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
I 型干扰素在调节 COVID-19 诱导的炎症和发病机制中的作用
  • 批准号:
    10321484
  • 财政年份:
    2020
  • 资助金额:
    $ 62.09万
  • 项目类别:
Support of Yerkes National Primate Research Center
耶基斯国家灵长类研究中心的支持
  • 批准号:
    10190517
  • 财政年份:
    2020
  • 资助金额:
    $ 62.09万
  • 项目类别:
4.7 T Small Aninal MR Imaging and Spectroscopy System
4.7T小型动物磁共振成像及光谱系统
  • 批准号:
    6501291
  • 财政年份:
    2002
  • 资助金额:
    $ 62.09万
  • 项目类别:
MR GUIDED THERMAL ABLATION OF ABDOMINAL TUMORS
MR 引导腹部肿瘤热消融
  • 批准号:
    6115296
  • 财政年份:
    1998
  • 资助金额:
    $ 62.09万
  • 项目类别:
Support of Yerkes National Primate Research Center
耶基斯国家灵长类研究中心的支持
  • 批准号:
    10089533
  • 财政年份:
    1997
  • 资助金额:
    $ 62.09万
  • 项目类别:
Emory National Primate Research Center
埃默里国家灵长类动物研究中心
  • 批准号:
    10648546
  • 财政年份:
    1997
  • 资助金额:
    $ 62.09万
  • 项目类别:
MR GUIDED THERMAL ABLATION OF ABDOMINAL TUMORS
MR 引导腹部肿瘤热消融
  • 批准号:
    6276530
  • 财政年份:
    1997
  • 资助金额:
    $ 62.09万
  • 项目类别:
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
Yerkes 国家灵长类动物研究中心 I 型 IFN 在调节 COVID-19 诱导的炎症和发病机制中的作用
  • 批准号:
    10400338
  • 财政年份:
    1997
  • 资助金额:
    $ 62.09万
  • 项目类别:
Support of Yerkes National Primate Research Center
耶基斯国家灵长类研究中心的支持
  • 批准号:
    9072055
  • 财政年份:
    1997
  • 资助金额:
    $ 62.09万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 62.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
    Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 62.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了